Skip to main content

Table 1 Characteristics of the Study Population.

From: Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphoma

  

Cases (%)

Controls (%)

Gender

 

Male

463 (58%)

423 (53%)

 

Female

334 (42%)

370 (47%)

Age group (years)

 

20-49

150 (19%)

208 (26%)

 

50-59

194 (24%)

169 (21%)

 

60-69

214 (27%)

206 (26%)

 

70+

239 (30%)

210 (26%)

Ethnicity

 

Caucasian

625 (78%)

613 (77%)

 

Asian

80 (10%)

90 (11%)

 

South Asian

29 (4%)

37 (5%)

 

Mixed/Other

36 (5%)

34 (4%)

 

Unknown/Refused

27 (3%)

19 (2%)

Pathology

   B-cell lymphomas

 

DLBCL

210 (26%)

-

 

FL1

138 (17%)

-

 

FL2/FL3

78 (10%)

-

 

MZL/MALT

92 (12%)

-

 

MCL

47 (6%)

-

 

SLL/CLL

43 (5%)

-

 

LPL

42 (5%)

-

 

MISC BCL

71 (9%)

-

   T-cell lymphomas

 

MF

40 (5%)

-

 

PTCL

29 (4%)

-

 

MISC TCL

7 (1%)

-

Total

 

797 (100%)

793 (100%)

  1. DLBCL = Diffuse Large B-Cell Lymphoma, FL = Follicular Lymphoma, FL1 = Follicular Lymphoma grade 1, FL2 = Follicular Lymphoma grade 2, FL3 = Follicular Lymphoma grade 3, MZ/MALT = Marginal Zone lymphoma/Mucosa-Associated Lymphoma Tissue lymphoma, MCL = Mantle Cell lymphoma, SLL = Small Lymphocytic Lymphoma, LPL = Lymphoplasmacytic Lymphoma, Misc. B-cell = Miscellaneous B-cell lymphoma, MF = Mycosis Fungoides, PTCL = Peripheral T-Cell Lymphoma, Misc. T-cell = Miscellaneous T-cell lymphoma.